Emi HIFUMI, Hiroaki TAGUCHI, Tamami NONAKA, Taizo UDA. Direct conversion of a general antibody to its catalytic antibody and corresponding applications -Importance and role of Pro95 in CDR-3-. Proceedings of the Japan Academy, Series B. 2023. 99. 6. 155-172
Tamami Nonaka, Hiroaki Taguchi, Taizo Uda, Emi Hifumi. Obtaining Highly Active Catalytic Antibodies Capable of Enzymatically Cleaving Antigens. International Journal of Molecular Sciences. 2022. 23. 22. 14351-14351
Emi Hifumi, Tamami Nonaka, Hiroaki Taguchi, Taizo Uda. A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain. Scientific Reports. 2022. 12. 1
Emi Hifumi, Hiroaki Taguchi, Tamami Nonaka, Takunori Harada, Taizo Uda. Finding and characterizing a catalytic antibody light chain, H34, capable of degrading the PD-1 molecule. RSC Chemical Biology. 2021. 2. 1. 220-229
Emi Hifumi, Hiroaki Taguchi, Haruna Tsuda, Tetsuro Minagawa, Tamami Nonaka, Taizo Uda. A new algorithm to convert a normal antibody into the corresponding catalytic antibody. Science advances. 2020. 6. 13. eaay6441